PR Newswire
PORTLAND, Ore., May 13, 2026
The global Cath Lab Services Market is experiencing substantial growth due to the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and growing technological advancements in cardiac catheterization laboratories. The increasing demand for image-guided diagnostic and therapeutic procedures across hospitals and specialty cardiac centers is significantly contributing to the growth of the market worldwide.
PORTLAND, Ore., May 13, 2026 /PRNewswire/ — Allied Market Research has published a comprehensive new research report, titled, «Cath lab services Market by Service Type (Diagnostic and Therapeutic), by Application (Cardiac and Brain & Spine), by Service Provider (Hospital and Individual Cath Labs): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global cath lab services market was valued at USD 46.0 billion in 2022, and is Anticipated to reach USD 78.2 billion by 2032, registering a CAGR of 5.4% from 2022 to 2032.
https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
Request Sample of the Report on Cath Lab Services Market Forecast 2035 –
https://www.alliedmarketresearch.com/request-sample/A11508
Rapidly rising prevalence of cardiac diseases such as coronary artery disease, angina, valvular disease, cardiomyopathy, endocarditis, congenital heart defects, and occlusive vascular disease and increasing demand for cath lab procedures such as angioplasty, angiography, stent placement and others are anticipated to boost the growth of market. However, high cost associated to cath lab services is anticipated to boost the growth of market. On the contrary, high presence of cath lab service providers and rise in initiative taken by government to develop healthcare infrastructure is expected to witness growth during the forecast period.
Key Market Insights
• The Cath Lab Services Market is gaining strong momentum due to rising adoption of minimally invasive cardiac procedures. Healthcare providers are increasingly preferring catheter-based interventions over traditional open-heart surgeries because these procedures offer faster recovery and reduced surgical risks.
• Another key trend driving the market is the integration of artificial intelligence and digital imaging technologies into cath lab systems. AI-enabled imaging solutions help physicians improve procedural accuracy, optimize workflow management, and enhance patient monitoring capabilities.
• Hybrid cath labs are also emerging as a major trend in the healthcare industry. These advanced laboratories combine surgical operating rooms with high-end imaging systems, enabling healthcare professionals to perform complex cardiovascular and vascular procedures in a single integrated environment.
• The growing use of robotic-assisted catheterization systems is further transforming the market. Robotic technologies help reduce physician radiation exposure and improve procedural precision during cardiovascular interventions.
• Moreover, increasing government initiatives and investments aimed at improving cardiac care infrastructure are expected to create lucrative growth opportunities for market players globally.
Market Size & Growth
The Cath Lab Services Market has witnessed notable expansion in recent years due to the increasing burden of cardiovascular diseases globally. Cardiac catheterization laboratories are specialized healthcare facilities equipped with advanced imaging systems used for diagnosing and treating heart-related disorders through minimally invasive procedures.
The growing incidence of coronary artery disease, arrhythmias, heart failure, and peripheral vascular diseases is creating strong demand for advanced cath lab systems. In addition, the aging global population and increasing prevalence of lifestyle-related disorders such as obesity, diabetes, hypertension, and high cholesterol are accelerating the adoption of interventional cardiology procedures.
Technological advancements in imaging systems, robotic-assisted catheterization procedures, and digital integration solutions are significantly improving procedural efficiency and patient outcomes. Modern cath labs now incorporate advanced fluoroscopy systems, 3D mapping technologies, AI-powered imaging software, and real-time navigation systems, which help physicians perform complex procedures with greater precision.
Furthermore, increasing healthcare investments, expansion of hospital infrastructure, and rising awareness regarding early diagnosis of cardiovascular diseases are expected to fuel market growth during the forecast period. The growing shift toward minimally invasive surgeries due to shorter recovery time, reduced complications, and lower hospitalization costs is also supporting market expansion.
Want to Explore More, Connect to our Analyst –
https://www.alliedmarketresearch.com/connect-to-analyst/A11508
Cath Lab Services Ecosystem Market Segmentation
By Service Type: Therapeutic vs. Diagnostic
The largest cath lab services market share of over three-fourths of global revenue in 2022 was held by the therapeutic segment. Growing occurrence of cardiac disorder and growing instances of brain and spine sickness is mainly fueling the worldwide interventional cardiology market boom. The rise in those conditions generates significant call for angioplasty, balloon valvuloplasty, stenting, cardiac ablation, pacemakers implantation process at some stage in these years. Therapeutics segment is anticipated to hold largest market share during forecast period. In fact, the diagnostic segment is expected to grow the fastest during the forecast period from 2023 – 2032, at a CAGR of 5.9 percent driven by increase in number of diagnostics carried out including coronary angiography, electrophysiological studies and intravascular imaging higher population awareness regarding cath lab diagnostic services for early detection of cardiovascular diseases.
By Application: Cardiac vs. Brain & Spine
The cardiac segment held more than four-fifths of the global cath lab services market share in 2022 and is expected to continue dominating the market from 2023 to 2030. This dominance mirrors the unparalleled burden of cardiovascular disease worldwide, escalated lifestyle-related risk factors such as inactive lifestyle, obesity, hypertension and diabetes, and increasing awareness among patients about catheter-based cardiac treatments. Although relatively small, the brain and spine segment is expected to demonstrate a high CAGR of 5.7% during the period (2023-2032) as it focuses on rising cases of brain tumor are already skyrocketing; according to American Cancer Society nearly 24,810 malignant brain or spinal cord tumors will be diagnosed in 2023 while increasing incidence and prevalence due to unstopped progression of any disease (e.g., brain aneurysm neural damage due to stroke neurovascular malformations).
By Service Provider: Hospitals versus Standalone Cath Labs
The largest share of service providers was represented by hospitals aging in more than two-thirds share of global revenue from the cath lab services market in 2022. Integrated emergency care infrastructure along with specialist departments of cardiology and neurology and institutional government support for improvement in health care infrastructure assists a hospital based cath lab. By end-use, the hospital segment is anticipated to register the highest CAGR of 5.6% during the forecast period from 2023 to 2032. Stand-alone cath labs such as ambulatory surgical centers (ASCs) and freestanding cardiac catheterization centersare appealing, less expensive, and shorter-stay procedural options that are becoming increasingly popular with patients and payers looking for efficient, high-quality outpatient cardiac care.
By Region: Of most of the regions, North America leads, Asia-Pacific rises with fastest growing CAGR
North America (Dominant Market – 40% Revenue Share in 2022): North America generated the highest revenue for the market, accounting for nearly two-fifths of global revenue in 2022. This leadership is a reflection of the high density of cath lab service providers, advanced hospital infrastructure (number of specialty procedures performed), per-capita healthcare expenditure and rapidly increasing population suffering from cardiovascular ailments Brain & spine diseases influencing overall Healthcare expenditure in Türkiye. The U.S. Centers for Disease Control and Prevention (CDC) estimates that about 695,000 Americans die from heart disease each year the number one cause of death in our nation providing a steady, high-volume market for cath lab diagnostic and therapeutic procedures. Medicare and private payers have developed robust reimbursement frameworks for cardiac catheterization procedures, which further supports the sustainability of market dynamics. North America is expected to continue holding the largest market share over the forecast period, backed by continued hospital capital investment in hybrid cath lab upgrades and AI-enabled imaging.
Europe (High-Value, Technology-Forward Market): Europe is the second largest cath lab services market, led by cumulative revenue from Germany, the UK, France, Italy and Spain. In 2022, Britain’s British Heart Foundation estimated around 1.139 million people were diagnosed with heart and circulatory diseases in UK illustrating clinical need tempo across the whole region. The focus of European healthcare systems on preventive cardiology, high uptake rates for advanced interventional technologies and a more attractive reimbursement framework for minimally invasive cardiac procedures have supported strong cath lab utilization in Europe. The March 2023 long-term strategic partnership between Royal Philips and the Gibraltar Health Authority to develop a new interventional cardiac cath lab suite exemplifies ongoing European capital investment in catheterization laboratory infrastructure.
Asia-Pacific: (Fastest Growing: 6.2% CAGR from 2023 to 2032) Asia-Pacific is likely the most dynamic regional growth opportunity, with cath lab services market $8 billion growing at a fast-paced rate of 6.2% throughout the forecast period and harvesting significant gains in terms of revenue during this forecasted timeframe reaching approx. The top growth drivers include the rapidly increasing aging population, particularly in Japan, China, South Korea and Australia prone to cardiovascular disorders; rising middle-class healthcare spend and insurance penetration across China; India and the rest of Southeast Asia; as well as robust support from government programs focused on modernizing healthcare infrastructure in specialized cardiac care capabilities. The emerging corporate hospital chains in India, headed by Apollo Hospitals, Fortis Healthcare and Manipal Hospitals are aggressively funding new cath lab installs. More traditional population-level dynamics supporting procedural volume growth in the forecast period include: China’s development of its national cardiovascular disease prevention strategy and Japan’s response to its aging society.
LATAM-MEA: represents the emerging opportunity region; Latin America, the Middle East and Africa persists as cath lab services markets that remain in-development but strategically relevant. Cardiac care networks have been created in Brazil and Mexico with an increasing volume of procedures in countries throughout Latin America. GCC countries particularly Saudi Arabia and the UAE focusing on hospital infrastructure improvements and developing specialized core of care cardiac centers to deliver comprehensive treatment as part of national healthcare reform agendas such as the one seen in Saudi Vision 2030. As the burden of cardiovascular disease is rising as countries urbanize and adopt other lifestyle changes, South Africa and select Sub-Saharan nations are relatively immature but growing markets for cath lab services.
For Purchase Related Queries/Inquiry-
https://www.alliedmarketresearch.com/purchase-enquiry/A11508
Leading Market Players: –
• Ochsner Rush Health
• Alberta Health Services
• Adventist Health Bakersfield
• Alliance Medical Associates
• Campbell Country Health
• Inhealthgroup
• Netcare Hospitals
• Ramsayhealth
• Canyon Vista Medical Center
• Henryford Health
The report provides a detailed analysis of these key players of the global Cath Lab Services Market. These players have adopted different strategies such as agreement, partnership, acquisition, and business expansion to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Key Recent Industry Developments
• With 2023-2026 set to be a key phase in the evolution of cath lab services, since several landmark technology innovations, strategic investments, and regulatory milestones have occurred recently; the following are three areas outlined to capture recent changes impacting global market dynamics.
• April 2023: The Alphenix system is a new interventional angiography technology revealed by Ramsay Health Care at its Sydney site, St George Private Hospital in the cardiac catheterization lab. This new technology gives cardiologists an order of magnitude clearer view of vascular tree structures while markedly lowering the total estimated dose for both patients and clinical staff during interventional angiography procedures a double crossroad in a cardiac catheterization share that sets higher standards on cath lab safety and diagnostic image quality.
• To expand patient care across radiology and cardiology, the Gibraltar Health Authority has signed a long-term strategic partnership with Royal Philips. Under the terms of the agreement, construction began on a new interventional cardiac suite (cath lab) signifying Philips’ commitment to embedding its Azurion image-guided therapy platform for new hospital infrastructure projects worldwide.
• March 2024: Philips Healthcare expands its interventional cardiology solutions portfolio with next-generation imaging systems specifically designed to aid in the performance of accurate, minimally invasive cardiac procedures. Respects Philips’ leadership position as a provider of AI-enabled cardiovascular imaging and integrated workflows: The launch helped to solidify Philips position as a leading-enabler in delivering high-performance cath lab environments.
• October 2024: GE HealthCare released a modular cath lab suite solution for small hospital and independent lab utilizations. With scalable design architecture and inbuilt diagnostic software, the solution allows budget-challenged healthcare providers to access enterprise-class cath lab capabilities – broadening the addressable market for cath lab services into new facility typologies and geographies.
• November 2024: Boston Scientific announced the launch of its second drug-eluting stent for use with 1.5 mm guidewires in high-volume cath lab environments, the new Synergy XD drug-eluting stent (DES). It accommodates a tangled coronary lesion profile, improves deliverability, and sustained drug elution can favourably influence long-term patient outcomes in an interventional cardiology context.
• January 2025: Medtronic won FDA approval for the Evolut FX+ transcatheter aortic valve replacement (TAVR) system, a state-of-the-art structural heart device suited to high-end cath labs. The approval is likely to significantly expand Medtronic’s presence in high-acuity interventional cath lab procedures and solidifies the paradigm shift toward catheter-based structural heart therapies away from open cardiac surgery.
Explore AMR’s Extensive Ongoing Coverage on Life Science Industry:
Skincare Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Medical Cannabis Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Healthcare Staffing Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Digital Pathology Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Health and Wellness Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of «Market Research Reports» and «Business Intelligence Solutions.» AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Logo – https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cath-lab-services-market-size-to-reach-56-2-billion-by-2031–globally-at-7-1-cagr-allied-market-research-302771103.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…